HomeNewsGlobal Pharma

India-UK FTA to Ease Regulatory Approvals, Boost Indian Pharma Exports: FIEO

India-UK FTA to Ease Regulatory Approvals, Boost Indian Pharma Exports: FIEO

The proposed India–UK Free Trade Agreement (FTA) is likely to deliver a significant boost across multiple industries in India, including pharmaceuticals, according to the Federation of Indian Export Organisations (FIEO).  

FIEO President S C Ralhan highlighted that sectors such as textiles, apparel, leather, gems and jewellery, pharmaceuticals, marine and engineering goods are poised to benefit substantially from the agreement.

He noted that the agreement is likely to eliminate tariffs on Indian garments and textiles, enhancing their competitiveness in the UK market, while also strengthening exports in high-value sectors like gems and jewellery and pharmaceuticals.

Importantly, the FTA is expected to streamline regulatory approvals for Indian pharmaceutical products in the UK.

On the UK side, the agreement is anticipated to reduce tariffs and expand exports in automotive, alcoholic beverages (notably whisky and gin), and high-end processed foods. Other sectors that may benefit include cosmetics, aerospace, medical devices, electrical machinery, and food products like lamb, salmon, soft drinks, chocolates, and biscuits.

FIEO welcomed Prime Minister Narendra Modi’s upcoming official visit to the UK and the Republic of Maldives from July 23–26, 2025, describing it as “a vital opportunity to deepen India’s global trade and investment partnerships.”

Ralhan said that the visit underscores India’s growing stature as a key player in the international economic arena.  

"This visit comes at a pivotal moment as negotiations for a Comprehensive Free Trade Agreement (FTA) are in the final stages. We are hopeful that high-level discussions will lead to greater consensus on trade facilitation measures and help realise the shared goal of doubling bilateral trade by 2030," he said.

This will mark PM Modi’s fourth visit to the UK and is expected to inject fresh momentum into the India–UK Comprehensive Strategic Partnership (CSP). The agenda will span key sectors including trade, technology, innovation, defence, climate change, health, education, and people-to-people ties.

Ralhan also noted that India and the UK enjoy a strong and evolving partnership.

FIEO commended the Indian government’s dynamic foreign policy outreach and expressed confidence that the Prime Minister’s engagements in both the UK and Maldives will significantly expand export opportunities, attract investments, and reinforce India’s position as a reliable and influential global economic partner.

More news about: global pharma | Published by Dineshwori | July - 23 - 2025 | 102

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members